SCPHARMACEUTICALS INC. - COMMON STOCK

scPharmaceuticals Inc. Reports First Quarter 2024 Financial Results and Provides Business Update

14 5 2024 16:01:00 提供 Nasdaq GlobeNewswire

scPharmaceuticals to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference

13 5 2024 16:05:00 提供 Nasdaq GlobeNewswire

scPharmaceuticals to Announce First Quarter 2024 Financial Results on Tuesday, May 14, 2024

07 5 2024 16:05:00 提供 Nasdaq GlobeNewswire

scPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector (furosemide 80mg/mL) Injection

24 4 2024 08:00:00 提供 Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

13 3 2024 16:01:00 提供 Nasdaq GlobeNewswire

scPharmaceuticals to Announce Fourth Quarter and Full-Year 2023 Financial Results on Wednesday, March 13, 2024

06 3 2024 16:01:00 提供 Nasdaq GlobeNewswire

scPharmaceuticals to Participate in Two Upcoming Investor Conferences

28 2 2024 16:01:00 提供 Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports Third Quarter 2023 Financial Results and Provides Business Update

08 11 2023 16:01:00 提供 Nasdaq GlobeNewswire

scPharmaceuticals to Announce Third Quarter 2023 Financial Results on Wednesday, November 8, 2023

01 11 2023 16:05:00 提供 Nasdaq GlobeNewswire

scPharmaceuticals to Participate in Two Upcoming Investor Conferences

31 10 2023 08:00:00 提供 Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

05 10 2023 08:00:00 提供 Nasdaq GlobeNewswire

scPharmaceuticals Announces Positive Feedback from Two FDA Meetings on Key Long-Term Growth Initiatives

19 9 2023 08:00:00 提供 Nasdaq GlobeNewswire

scPharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

05 9 2023 08:00:01 提供 Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update

10 8 2023 16:01:00 提供 Nasdaq GlobeNewswire

scPharmaceuticals to Announce Second Quarter 2023 Financial Results on Thursday, August 10, 2023

03 8 2023 08:00:00 提供 Nasdaq GlobeNewswire

scPharmaceuticals Announces Positive Type C Meeting Feedback from FDA on Potential Heart Failure Class IV Indication Expansion

01 8 2023 08:00:00 提供 Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

19 7 2023 08:00:01 提供 Nasdaq GlobeNewswire

scPharmaceuticals Inc. Announces Addition to Russell 2000® and Russell 3000® Indexes

23 6 2023 08:00:00 提供 Nasdaq GlobeNewswire

scPharmaceuticals to Present at the Jefferies Healthcare Conference

31 5 2023 08:00:00 提供 Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports First Quarter 2023 Financial Results and Provides Business Update

10 5 2023 16:01:00 提供 Nasdaq GlobeNewswire